The amount of the deal was not disclosed.
This acquisition aims to expand Ever Pharma’s commercial footprint in Germany.
Amneal Deutschland already distributes several Ever Pharma products in Germany and is an established player in the German hospital market.
The acquired entity will be rebranded to Ever Pharma GmbH.
Ever Pharma is a fully integrated specialty pharmaceuticals company focused on the research, development, production and commercialization of products in the areas of neurology, critical care, anesthesia and oncology. The company markets in over 70 countries through wholly owned affiliates and distribution partners.
Founded in 1934, the company has approx. 820 employees. In Austria, it manufactures active ingredients for in-house use. In Germany, Ever is a full-service provider focusing on the manufacturing of sterile injectables in ampoules, vials, prefilled syringes and implants having the capabilities for manufacturing of complex drug products like crystal-suspensions, oily solutions, highly actives and narcotics.
The German site also offers fill/finish services for 3rd party clients.
FinSMEs
24/05/2019